Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001029142-25-000071
Filing Date
2025-05-06
Accepted
2025-05-06 16:16:04
Documents
80
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q dvax-20250331.htm   iXBRL 10-Q 1481752
2 EX-31.1 dvax-20250331xex311.htm EX-31.1 10507
3 EX-31.2 dvax-20250331xex312.htm EX-31.2 10849
4 EX-32.1 dvax-20250331xex321.htm EX-32.1 6195
5 EX-32.2 dvax-20250331xex322.htm EX-32.2 6179
  Complete submission text file 0001029142-25-000071.txt   8041086

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dvax-20250331.xsd EX-101.SCH 57892
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dvax-20250331_cal.xml EX-101.CAL 75742
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dvax-20250331_def.xml EX-101.DEF 282111
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dvax-20250331_lab.xml EX-101.LAB 731984
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dvax-20250331_pre.xml EX-101.PRE 515620
83 EXTRACTED XBRL INSTANCE DOCUMENT dvax-20250331_htm.xml XML 1045993
Mailing Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 720 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34207 | Film No.: 25917484
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)